Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043) | MicrobiomeTrials← Back to trialsNCT07405164
Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2026-03-23Est. Completion: 2034-01-14
Enrollment target: 450 participants Locations- Beth Israel Deaconess Medical Center ( Site 0107), Boston, Massachusetts, United States
- Dana-Farber Cancer Institute ( Site 0105), Boston, Massachusetts, United States
- Karmanos Cancer Center ( Site 0108), Detroit, Michigan, United States
- Hospital of the University of Pennsylvania Perelman Center for Advanced Medicine ( Site 0100), Philadelphia, Pennsylvania, United States
- SCRI Oncology Partners ( Site 7000), Nashville, Tennessee, United States
- START San Antonio ( Site 0104), San Antonio, Texas, United States
- Fred Hutchinson Cancer Center ( Site 0106), Seattle, Washington, United States
- St George Hospital-Oncology Clinical Research Unit ( Site 2701), Kogarah, New South Wales, Australia
- Westmead Hospital ( Site 2703), Sydney, New South Wales, Australia
- UZ Leuven ( Site 0900), Leuven, Vlaams-Brabant, Belgium
- BP - A Beneficencia Portuguesa de São Paulo ( Site 0200), São Paulo, São Paulo, Brazil
- Département clinique de médecine de laboratoire du CHUM ( Site 0001), Montreal, Quebec, Canada
- James Lind Centro de Investigacion del Cancer ( Site 0304), Temuco, Araucania, Chile
Other microbiome trials you might be interested in
AdenocarcinomaProstate NeoplasmsProstate CancerRenal Cell CarcinomaVon Hippel Lindau Disease
This study will evaluate the accuracy and effectiveness of an experimental tracking device for locating abnormalities du…
Bethesda, United StatesCompleted Aug 2, 2028
Kidney CancerUrologic Malignant DisordersRenal Cell CarcinomaFamilial Renal Cancer (FRC)Clear Cell Renal Cancer
We will investigate the clinical manifestations and molecular genetic defects of heritable urologic malignant disorders.…
CIDO SpA ( Site 0305), Temuco, Araucania, ChileFALP ( Site 0300), Santiago, Region M. de Santiago, ChileOncovida ( Site 0303), Santiago, Region M. de Santiago, ChileBradfordhill ( Site 0301), Santiago, Region M. de Santiago, ChileONCOCENTRO APYS ( Site 0302), Viña del Mar, Valparaiso, ChileFakultni nemocnice Olomouc-Onkologicka klinika ( Site 1000), Olomouc, CzechiaHerlev and Gentofte Hospital ( Site 1200), Herlev, Capital Region, DenmarkTampereen yliopistollinen sairaala ( Site 1305), Tampere, Pirkanmaa, FinlandHôpitaux Universitaires de Strasbourg ( Site 1702), Strasbourg, Bas-Rhin, FranceInstitut Claudius Regaud ( Site 1703), Toulouse, Haute-Garonne, FranceOrszágos Onkológiai Intézet-Urogenitális Tumorok és Klinikai Farmakológiai Osztály ( Site 1501), Budapest, HungaryRambam Health Care Campus ( Site 1600), Haifa, IsraelHadassah Medical Center ( Site 1604), Jerusalem, IsraelRabin Medical Center ( Site 1602), Petah Tikva, IsraelSheba Medical center ( Site 1601), Ramat Gan, IsraelSourasky Medical Center ( Site 1603), Tel Aviv, IsraelKyushu University Hospital ( Site 3101), Fukuoka, JapanMaastricht Universitair Medisch Centrum - MUMC ( Site 1900), Maastricht, Limburg, NetherlandsIsala, locatie Zwolle ( Site 1902), Zwolle, Overijssel, NetherlandsAuckland City Hospital ( Site 3000), Auckland, New ZealandZakład Diagnostyki Laboratoryjnej, Centrum Onkologii ( Site 2000), Bydgoszcz, Kuyavian-Pomeranian Voivodeship, PolandN.N. Blokhin NMRCO ( Site 2101), Moscow, Moscow, RussiaRussian Scientific Center of Radiology and Surgical Technologies ( Site 2100), Saint Petersburg, Sankt-Peterburg, RussiaSamsung Medical Center ( Site 2902), Gangnam, Seoul, South KoreaSeverance Hospital, Yonsei University Health System ( Site 2901), Seodaemun-gu, Seoul, South KoreaAsan Medical Center ( Site 2900), Seoul, South KoreaHospital Universitari Vall d'Hebron ( Site 2300), Barcelona, SpainHospital Universitario 12 de Octubre ( Site 2301), Madrid, SpainTaipei Veterans General Hospital ( Site 2800), Taipei, TaiwanME І.І. Mechnykov Dnipro Regional Clinical Hospital ( Site 2601), Dnipropetrovsk, Dnipropetrovsk Oblast, UkraineCNCE Precarpathian Clinical Oncologic Center ( Site 2600), Ivano-Frankivsk, Ivano-Frankivsk Oblast, UkraineThe Beatson West of Scotland Cancer Centre ( Site 2505), Glasgow, Glasgow City, United KingdomSt Bartholomew's Hospital ( Site 2500), London, London, City of, United KingdomROYAL MARSDEN HOSPITAL (CHELSEA) ( Site 2502), London, London, City of, United KingdomImperial College Healthcare NHS Trust, Charing Cross Hospital ( Site 2504), London, London, City of, United KingdomThe Christie NHS Foundation Trust ( Site 2501), Manchester, United Kingdom